Anaptysbio (ANAB) Notes Payables (2017 - 2019)

Anaptysbio has reported Notes Payables for 3 years, with the latest figure at $1.4 million in Q4 2019.

• For the quarter ending Q4 2019, Notes Payables fell 81.85% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2019 stood at $1.4 million (down 81.85% YoY), and the FY2019 full-year result was $1.4 million, down 81.85% from the prior year.
• Notes Payables for Q4 2019 stood at $1.4 million, down from $3.1 million in the prior quarter.
• The five-year high for Notes Payables was $7.6 million in Q4 2018, with the low at $1.2 million in Q1 2017.
• Historically, Notes Payables has averaged $5.2 million across 3 years, with a median of $5.7 million in 2017.
• Annual changes were most pronounced in 2018 — Notes Payables soared 500.0% — and 2019, when it sank 81.85%.
• Anaptysbio's Notes Payables stood at $6.9 million in 2017, then grew by 10.17% to $7.6 million in 2018, then tumbled by 81.85% to $1.4 million in 2019.
• The last three Notes Payables figures came in at $1.4 million (Q4 2019), $3.1 million (Q3 2019), and $4.8 million (Q2 2019), per Business Quant data.